Susan ALTSCHULLER insider trades

Open-market stock purchases and sales by Susan ALTSCHULLER, Chief Financial Officer at Climb Bio, Inc, from SEC Form 4 filings since Jul 20, 2020.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -36%.

Recent trades

DateStockTradeValue
Jan 6, 2026CLYM Climb Bio, IncBought (not open market)—

Companies traded

  • CLYM Climb Bio, Inc: other filings, last Jan 6, 2026
  • MURA Mural Oncology plc: 1 buy, last Aug 14, 2024
  • CERE Cerevel Therapeutics Holdings, Inc: 1 sale, last Aug 1, 2024
  • IMGN ImmunoGen, Inc: other filings, last Nov 14, 2022

Get free alerts when Susan ALTSCHULLER files a new trade →